SEARCH

SEARCH BY CITATION

References

  • 1
    Georgopoulos K, Bigby M, Wang J-H et al. The Ikaros gene is required for the development of all lymphoid lineages. Cell 1994; 79: 14356.
  • 2
    Winandy S, Wu P, Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 1995; 83: 28999.
  • 3
    Wang J-H, Nichogiannopoulou A, Wu L et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996; 5: 53749.
  • 4
    Nakayama H, Ishimaru F, Avitahl N et al. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia. Cancer Res 1999; 59: 39314.
  • 5
    Nakase K, Ishimaru F, Avitahl N et al. Dominant-negative isoform of Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia. Cancer Res 2000; 60: 40625.
  • 6
    Molnar A, Georgopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA binding proteins. Mol Cell Biol 1994; 14: 8292303.
  • 7
    Sun L, Liu A, Georgopoulos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J 1996; 15: 535869.
  • 8
    Morgan B, Sun L, Avitahl N et al. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J 1997; 16: 200413.
  • 9
    Wang J-H, Avitahl N, Cariappa A et al. Aiolos regulates B cell activation and maturation to effector state. Immunity 1998; 9: 54353.
  • 10
    Hahm K, Cobb BS, McCarty AS et al. Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev 1998; 12: 78296.
  • 11
    Kelley CM, Ikeda T, Koipally J et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol 1998; 8: 50815.
  • 12
    Nakase K, Ishimaru F, Fujii K et al. Overexpression of novel short isoforms of Helios in a patient with T-cell acute lymphoblastic leukemia. Exp Hematol 2002; 30: 31317.
  • 13
    Fujii K, Ishimaru F, Nakase K et al. Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma. Br J Haematol 2003; 120: 9869.
  • 14
    Ishimaru F, Mari B, Shipp MA. The type 2 CD10/neutral endopeptidase 24.11 promoter: functional characterization and tissue-specific regulation by CBF/NF-Y isoforms. Blood 1997; 89: 413645.
  • 15
    Koipally J, Heller EJ, Seavitt JR, Georgopoulos K. Unconventional potentiation of gene expression by Ikaros. J Biol Chem 2002; 277: 13007 – 15.
  • 16
    Koipally J, Georgopoulos K. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J Biol Chem 2000; 275: 19594 – 602.